We are live on ! Find out more
TNON icon

Tenon Medical

6 hedge funds and large institutions have $48.6K invested in Tenon Medical in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 0.05%0.06% (+0%)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

14% less funds holding

Funds holding: 76 (-1)

86% less capital invested

Capital invested by funds: $347K → $48.6K (-$299K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change

TNON Hedge Fund Activity: Q3 2024 in Review

6 of the 6,969 institutional investors tracked by Wall St. Rank reported a position in Tenon Medical (TNON) for Q3 2024, worth a combined $48.6K — down 86% from $347K a quarter earlier.

Fund positioning in TNON was balanced in Q3 2024: 3 funds opened new positions, 3 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $3.71K. The largest seller was Geode Capital Management, exiting entirely with an estimated $17.8K sold.

  • 6 institutional investors held Tenon Medical (TNON) as of Q3 2024, down from 7 in Q2 2024.
  • Funds reported $48.6K of Tenon Medical stock for Q3 2024, down 86% quarter-over-quarter.
  • 3 funds opened new Tenon Medical positions in Q3 2024 and 3 closed out, a net change of 0 holders.
  • The largest Tenon Medical buyer in Q3 2024 was Morgan Stanley, an estimated $3.71K added.
  • The largest Tenon Medical seller in Q3 2024 was Geode Capital Management, an estimated $17.8K sold.

Based on aggregated 13F filings for Q3 2024.